Rapid Micro Biosystems is a life sciences technology company providing automation solutions to facilitate the manufacturing and healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Co.'s primary Growth Direct platform automates the antiquated, manual microbial quality control (MQC), testing workflows used in pharmaceutical manufacturing operations. Co.'s Growth Direct platform automates and digitizes the MQC and enables customers to perform this testing process. Co.'s platform comprises the Growth Direct system, proprietary consumables, laboratory information management system connection software, and customer support and validation services. We show 14 historical shares outstanding datapoints in our coverage of RPID's shares outstanding history.
Understanding the changing numbers of RPID shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like RPID versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching RPID by allowing them to research RPID shares outstanding history
as well as any other stock in our coverage universe. |
Free RPID Email Alerts:
Video: Shares Outstanding Importance
